Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts
Benjamin J. Drapkin(Southwestern Medical Center), Anna F. Farago(Massachusetts General Hospital), Stefan A. Haas(Max Planck Institute for Molecular Genetics), Reinhard Büttner(University Hospital Cologne), Kandarp Jani(Dana-Farber Cancer Institute), Camilla L. Christensen(Dana-Farber Cancer Institute), Kwok‐Kin Wong(NYU Langone Health), Mehlika Hazar-Rethinam(Massachusetts General Hospital), Peter Igo(Massachusetts General Hospital), Nima Abedpour(University of Cologne), Daniel A. Haber(Howard Hughes Medical Institute), Nicholas J. Dyson(Massachusetts General Hospital), Roman K. Thomas(University of Cologne), Rebecca S. Heist(Massachusetts General Hospital), Joseph A. LiCausi(Harvard University), Marina Kem(Massachusetts General Hospital), Martin Peifer(University of Cologne), Shyamala Maheswaran(Massachusetts General Hospital), Mari Mino–Kenudson(Massachusetts General Hospital), María Gomez‐Caraballo(Massachusetts General Hospital), Lecia V. Sequist(Harvard University), Mehmet Toner(Center for Cancer Research), Roopika Menon, Sotirios Lakis(Integrated Oncology (United States)), Alice T. Shaw(Dana-Farber Cancer Institute), Jun Zhong(Massachusetts General Hospital), Roxana Azimi(Massachusetts Institute of Technology), Aaron N. Hata(Harvard University), David T. Myers(Harvard University), Julie George(University of Cologne), Sarah Phat(Harvard University), Tilak Sundaresan(Kaiser Permanente San Francisco Medical Center), Ruben Dries(Boston University)
Cited by 216
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
|New England Journal of Medicine|2013|3.4k
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
|Journal of Clinical Oncology|2013|3.2k